{
    "clinical_study": {
        "@rank": "144562", 
        "arm_group": [
            {
                "arm_group_label": "Lactol", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Some evidences have shown that probiotics are effective in the treatment of irritable bowel\n      syndrome. Because few evidences are available in our population, we investigated if\n      probiotics are effective in our patients as well. We hypothesize that the probiotic Lactol\n      which contains Lactobacillus Sporogenes reduces the symptoms of irritable bowel syndrome."
        }, 
        "brief_title": "Probiotics in the Treatment of Irritable Bowel Syndrome", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Irritable Bowel Syndrome", 
        "condition_browse": {
            "mesh_term": "Irritable Bowel Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age between 18 and 65\n\n          -  diagnosis of IBS based on the Rome III criteria\n\n          -  willingness to participate\n\n        Exclusion Criteria:\n\n          -  receiving other probiotics compound during the study\n\n          -  receiving antibiotics during the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "82", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01837485", 
            "org_study_id": "15010101882058"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lactol", 
                "description": "The Symbiotic Lactol\u00ae (Bioplus Life Sciences Pvt.) was applied 3 times a day for 3 months. Lactol is composed of the followings; Lactobacillus Sporogenes (15 \u00d7 107 Spores), Fructo-Oligosaccharides, Microcrystalline Cellulose, Sodium starch Glycolate, Povidone, Hypermellose Stearate, Sillicon Dioxide, and Propylene Glycol.", 
                "intervention_name": "Lactol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo pill was applied 3 times a day for 3 months", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Irritable bowel syndrome", 
            "Functional gastrointestinal disorders", 
            "Gut flora", 
            "Probiotics"
        ], 
        "lastchanged_date": "April 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Isfahan", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Shariati Hospital"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of the Effects of Lactol Probiotic in Comparison With Placebo on Symptoms of Irritable Bowel Syndrome", 
        "overall_official": {
            "affiliation": "Islamic Azad University, Najafabad Branch", 
            "last_name": "Mozhdeh Zahiri, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Abdominal pain was assessed by Rome III questionnaire at baseline and then after 3 months.", 
                "measure": "Abdominal pain", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 months"
            }, 
            {
                "description": "Constipation was assessed by Rome III questionnaire at baseline and then after 3 months.", 
                "measure": "Constipation", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 months"
            }, 
            {
                "description": "Diarrhea was assessed by Rome III questionnaire at baseline and then after 3 months.", 
                "measure": "Diarrhea", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01837485"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Islamic Azad University, Najafabad Branch", 
            "investigator_full_name": "Mozhdeh Zahiri", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Islamic Azad University, Najafabad Branch", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Islamic Azad University, Najafabad Branch", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}